Valuation: Merck KGaA

Market Cap 65.78B 73.45B 60.51B 54.83B 102B 6,974B 104B 722B 290B 3,669B 276B 270B 11,569B P/E 2026 *
25.2x
P/E 2027 * 22.2x
Enterprise Value 73.52B 82.09B 67.62B 61.27B 115B 7,794B 117B 806B 324B 4,100B 308B 302B 12,930B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.15x
Free-Float
29.73%
Yield 2026 *
1.55%
Yield 2027 * 1.59%
1 day+0.67%
1 week+5.58%
1 month+9.56%
3 months+5.69%
6 months+37.48%
Current year+23.41%
1 week 142.05
Extreme 142.05
152.1
1 month 132.95
Extreme 132.95
152.1
Current year 100.7
Extreme 100.7
152.1
1 year 100.7
Extreme 100.7
152.1
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 61 01/05/2026
Director of Finance/CFO 56 01/07/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 26/04/2019
Director/Board Member 60 09/05/2014
Director/Board Member 50 28/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
25/03/26 Buy

Chief Executive Officer

3,386 0.0026%
25/03/26 Buy

Chief Financial Officer

4,563 0.0035%
27/03/25 Buy 1,401 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%+5.58%+33.36%+6.29% 73.45B
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.94%+5.87%+45.26%+76.73% 433.54B
Weighted average by Cap. +1.98%+6.58%+50.22%+98.84%

Financials

2026 *2027 *
Net sales 21.55B 24.06B 19.82B 17.96B 33.57B 2,284B 34.19B 236B 94.87B 1,202B 90.28B 88.36B 3,789B 22.74B 25.39B 20.92B 18.96B 35.43B 2,411B 36.1B 249B 100B 1,268B 95.3B 93.28B 4,000B
Net income 2.6B 2.9B 2.39B 2.17B 4.05B 276B 4.13B 28.52B 11.45B 145B 10.9B 10.66B 457B 2.9B 3.24B 2.67B 2.42B 4.53B 308B 4.61B 31.86B 12.79B 162B 12.17B 11.91B 511B
Net Debt 7.73B 8.64B 7.11B 6.45B 12.05B 820B 12.28B 84.84B 34.06B 431B 32.41B 31.72B 1,360B 5.8B 6.48B 5.34B 4.84B 9.04B 615B 9.21B 63.67B 25.56B 324B 24.32B 23.81B 1,021B
Projected Income Statement - Annual - Merck KGaA
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
62,136
Date Price Change Volume
30/10/26 €151.30 +0.67% 380,907
29/10/26 €150.30 +2.91% 268,918
28/10/26 €146.05 +1.07% 206,624
27/10/26 €144.50 +0.63% 185,260
26/10/26 €143.60 +0.21% 159,035
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Merck KGaA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
151.30EUR
Average target price
155.07EUR
Spread / Average Target
+2.49%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Merck KGaA